Could an arginine supplement supercharge your immune system against cancer and viruses?

A surprisingly simple nutrient could hold the key to stronger immune defenses. Researchers at Rockefeller University discovered that when arginine — a common amino acid found in protein-rich foods — runs low, the body's immune system loses its ability to spot cancer cells and viral invaders. The culprit: arginine-starved ribosomes stall while building MHC-I proteins, the molecular "ID badges" that flag dangerous cells for immune destruction. Fewer MHC-I proteins on cell surfaces means fewer alerts sent to T cells — and more opportunities for threats to slip through undetected.

In mouse studies, a higher-arginine diet led to fewer colon cancer tumors and milder flu and COVID-19 symptoms. Even more striking, giving mice arginine after they were already infected with influenza improved their recovery — suggesting the supplement could have therapeutic, not just preventive, value. The findings, published in Cell, open the door to testing arginine alongside existing cancer immunotherapies or in high-risk populations facing respiratory viruses.

Key Takeaways

• Arginine deficiency impairs MHC-I protein production, reducing immune recognition of cancer and viral threats
• Arginine supplementation post-influenza infection improved outcomes in mice — a finding researchers described as "very surprising"
• Arginine levels naturally decline with age, potentially contributing to immune vulnerability in older adults

Why it matters: Because arginine is inexpensive and widely available, it could be a practical, low-barrier addition to cancer immunotherapy regimens or viral infection prevention strategies — pending human trials.